Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Sublease Agreement (Tables)

3 Months Ended

Mar. 31, 2016

The changes in the liability related to the sublease agreement for the three months ended March 31, 2016 were as follows (in thousands):


Balance at January 1, 2016	$	6,465
Accretion of deferred liability		109
Amortization of deferred liability		(841)
Balance at March 31, 2016	$	5,733